SomnoMed Limited
ASX: SOM.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Amrita Blickstead
- Employees
- 300
- Headquarters
- Crows Nest, Australia
- IPO year
- 2004
- Market cap
- A$131.4M
- Website
- https://somnomed.com
Loading SOM…
Loading profile data…Frequently asked questions about SOM
What does SomnoMed Limited (SOM.AX) do?
SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. It offers SomnoDent, an oral appliance for obstructive sleep apnea; SomnoBrux, a dental guard for the treatment of teeth grinding damage; SomMorni...
Where does SOM.AX trade?
SomnoMed Limited (SOM.AX) trades on the Australian Securities Exchange.
What sector is SOM.AX in?
SomnoMed Limited (SOM.AX) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of SomnoMed Limited?
Amrita Blickstead is the chief executive officer of SomnoMed Limited (SOM.AX).
Where is SomnoMed Limited headquartered?
SomnoMed Limited is headquartered in Australia.
Does SOM.AX pay a dividend?
SomnoMed Limited (SOM.AX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SOM.AX go public?
SomnoMed Limited (SOM.AX) completed its initial public offering in 2004.